1. P582: FIRST RESULTS OF A PHASE II STUDY (STIMULUS-AML1) INVESTIGATING SABATOLIMAB + AZACITIDINE + VENETOCLAX IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Zeidan, A. M.; Westermann, J.; Kovacsovics, T.; Assouline, S.; Schuh, A. C.; Kim, H.-J.; Rodriguez Macias, G.; Sanford, D.; Luskin, M. R.; Stein, E. M.; Malek, K.; Lyu, J.; Stegert, M.; Esteve, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗